medmix AG
Company Profile
Business Description
medmix AG is a Swiss-based global leader in designing, developing, manufacturing, and delivering high-precision delivery devices and fluid mixing technologies. The company operates across two primary segments: Healthcare, encompassing Dental, Drug Delivery, and Surgery, and Consumer & Industrial, including Industry and Beauty applications. In Healthcare, it provides products like mixing tips, cartridges for prosthetics, restorations, anesthetics, and aesthetics; drug delivery devices for fertility drugs, growth hormones, diabetes, osteoporosis, and rare diseases; and surgical tools for bone tissue injection and hemostatic sealants. The Consumer & Industrial segment supplies dispensers, cartridges, mixers for two-component adhesives in construction, transportation (automotive, railways, aerospace), electronics, infrastructure, and DIY, alongside micro-brushes for makeup and skincare. Brands include MIXPAC, transcodent, Haselmeier, Geka, and others. With over 900 active patents, 14 production sites worldwide, and approximately 2,700 employees, medmix drives innovation in these markets, stemming from a 2021 spin-off from Sulzer.
Profitability & Growth
Profitability
Recent Year-End
Balance Sheet Snapshot
Total Cash (MRQ)
113.9M
Total Debt (MRQ)
334.4M
Current Ratio (MRQ)
1.54
Book Value / Share
10.47